U-M Health Earns AHA Honor for Aortic Stenosis Care
The University of Michigan Health System has been recognized by the American Heart Association for achieving the Target: Aortic Stenosis™ Honor Roll award through its commitment to improving care for this undertreated heart valve disease.
Aortic stenosis (AS) is one of the most common and serious heart valve disease problems. More than 1.7 million Americans over age 65 have severe aortic stenosis, and without valve replacement, as few as half survive beyond two years. However, many patients are unaware or undiagnosed, which is why the American Heart Association continues to drive efforts for timely diagnosis, appropriate treatment, improved quality of care initiatives and comprehensive patient and caregiver resources to combat the disease.
“We are proud to be recognized for our team’s dedication to improving heart valve disease care and treatment,” said Hakan Oral, MD, Chief, Division of Cardiovascular Medicine. “The Target: Aortic Stenosis program helps us to optimize treatment pathways and bring together the patient, caregivers and providers to determine the best way forward.”
The American Heart Association launched Target: Aortic Stenosis to improve patient outcomes, starting at symptom onset and diagnosis through timely and appropriate treatment. The program consists of evidence-based measure development to better identify and treat patients, as well as multi-media educational resources for patients and health care professionals.
Learn more at heart.org/TargetAS
Featured News & Stories
Rare genetic eye disease treated with gene therapy helps 2 children see again
Rethinking how clinicians learn to feel disease
College of Pharmacy alum advances U-M Medical School addiction research
Born with half a heart, headed to college with a full life
MD/PhD student Brandon Lu receives a predoctoral fellowship from the National Institutes of Health